Home » Newsletters » BioWorld Science

BioWorld Science

Jan. 22, 2021

View Archived Issues

Bio-Thera Solutions initiates phase I study of BAT-1308 in advanced solid tumors

Target enrollment complete in diabetic foot ulcer study of SkinTE

EuBiologics receives IND approval in Korea for its COVID-19 vaccine candidate

FDA clears IND for phase II study of LTX-315

U.S. IND application cleared for UX-701 gene therapy for Wilson disease

Codiak Biosciences describes extracellular vesicles targeting T cells

Cell therapy targeting BCL11A gene safely induces erythrocyte fetal hemoglobin

Lyndra initiates phase I study of its rosuvastatin extended-release capsule

First participants dosed in phase II study of MV-012-968

Tau end run prevents memory deficits, but not inflammation

SCLC subtypes have specific vulnerabilities

Sunshine Lake Pharma discovers ACC1/ACC2 inhibitors

INmune Bio reports biomarker data from phase Ib study of XPro-1595 in Alzheimer's

Addition of tocilizumab does not improve clinical outcome in severe or critical COVID-19

New STING modulators identified at Camphor Pharmaceuticals

New chymase inhibitors patented by Medshine Discovery

SC-75741 potently inhibits the replication of bandaviruses in vitro

Phase II trial of SURF-201 for post-cataract surgery pain and inflammation meets endpoints

UCB describes new dopamine D1 receptor PAMs

FDA approves Cabenuva long-acting regimen for HIV-1 infection in adults

Oramed begins randomization in phase III study of oral insulin capsule ORMD-0801

ARB-202: a bispecific MAb useful against CDH17-positive GI cancers

SFX-01 shrinks tumors and extends survival in preclinical models of glioma and glioblastoma

Sutro begins ovarian cancer dose-expansion cohort in phase I study of STRO-002

Phase III data show bamlanivimab reduces risk of symptomatic COVID-19 in nursing homes

Partial clinical hold lifted on phase I studies of PRS-343

Adlumiz approved in Japan for cancer cachexia

European Commission approves Elzonris for blastic plasmacytoid dendritic cell neoplasm

GSK discontinues phase II trial of GSK-2831781 in ulcerative colitis

Aging immune cell energy "hoarders" play role in brain decline

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 8, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 8, 2025.
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
Brenig Therapeutics discovers new LRRK2 inhibitors
BioWorld Science
Brenig Therapeutics Inc. has described leucine-rich repeat kinase 2 (LRRK2; dardarin) and (LRRK2; dardarin) (G2019S mutant) inhibitors reported to be useful for...